Opinion

The June issue of Pharmaceutical Commerce is headlined by a look at the influence of artificial intelligence and real-world evidence/real-world data on patient behavior and ultimately, the many complex factors that go into medicine adherence.

Beneath all the “organized chaos,” industry shows such as LogiPharma Europe spotlight the valuable opportunity offered by these events to further educate our most valuable asset: our readers.

An exploration of the new demands in cold-chain visibility and sustainability—and the resulting tech-driven efforts to address them—leads off our coverage in this month's issue.

We'll be back in Lyon, France, this month to capture the latest insights and advances in pharma logistics—as leaders seek to build the supply chains of the future.

A dive into the intricacies of how to ensure a long-running event stays fresh and relevant to the needs of the pharmaceutical industry.

The February issue is centered around third-party logistics providers, including new dynamics and future trends that affect this key supply chain link.

Pharma Commerce's new style is built off of the back of our new and improved editorial calendar.

While often portrayed in a negative light, it is important to find a balanced perspective on its role in the pharma sector.

December's installment reinforces the publication's commitment to covering the latest updates on patient support.

Introducing a new style and feel to Pharma Commerce.

Although companies are faced with constraints, regulations, and challenges in this space, the positives supersede the negatives.

A breakdown on the decision, and how to navigate these obstacles using a network approach.

How the links of the supply chain are fighting to preserve quality service, even against factors that may be out of their hands.

October's issue continues its dedicated coverage surrounding the cold chain.

A reflection on my time with Pharma Commerce thus far, and a plan of action for moving the brand forward.

A look into ways to approach change management using three factors.

How drugmakers can navigate the program’s pricing challenges and regulatory developments.

Shift focus in orphan and ultra-orphan messaging to clinical benefit.

The August issue varies in subject matters, from the outlook for drug wholesaling to the value of a user-centric approach for drug adherence.

As Pharma Commerce continues to increase its conference exposure, it all could not have been possible without the help of colleagues.

The importance of industry, as it moves forward, in focusing on patient-centered care and prioritizing patient needs across the supply chain.

Micah Litow, Kalderos’ president and COO, discusses the importance of identifying and resolving noncompliant discount requests, along with addressing the gross-to-net gap for drug manufacturers.

The legislation’s deadline for compliance is knocking on the door. Pharma Commerce offers a synopsis of how the Drug Supply Chain Security Act has progressed over the past decade.

The publication's June installment features a plethora of coverage, ranging from the learning curve in digital adoption to an overview of the CVD market.

As the brand looks to increase its coverage, Pharma Commerce welcomes a pair of editorial contributors to the team.

Although there is no ‘one size fits all’ solution, the process is influenced by factors such as lifestyle stage, competitive outlook, and market constraints.

DSCSA, 340B among the headliners at the Healthcare Distribution Alliance's Distribution Management Conference.

How molding these elements into one can add efficiencies to work processes.

Why automation-enabling tech—such as NLP and ML—can help improve medicine effectiveness.

Senate committee report highlights a lack of visibility in API suppliers.